Administration for Market Regulation fined three enterprises heavily for drug monopoly

Summary: The Administration for Market Regulation issued a notice on 14 April to fine three enterprises for their monopoly actions on API, with a penalty of USD45.99 million (RMB325.5 million). It is the heaviest fine for an antitrust case in China's...

Vitamins China E-News 202004

www.cnchemicals.com